Amundi’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.82M Sell
87,218
-878
-1% -$90.9K ﹤0.01% 917
2026
Q1
$8.52M Sell
88,096
-2,319
-3% -$238K ﹤0.01% 895
2025
Q4
$9.6M Buy
90,415
+2,300
+3% +$267K ﹤0.01% 945
2025
Q3
$10.9M Sell
88,115
-104,197
-54% -$12.4M ﹤0.01% 846
2025
Q2
$22.9M Buy
192,312
+7,552
+4% +$863K 0.01% 686
2025
Q1
$18.8M Sell
184,760
-7,512
-4% -$733K 0.01% 721
2024
Q4
$17.9M Sell
192,272
-137,419
-42% -$13.5M 0.01% 740
2024
Q3
$30.8M Buy
329,691
+329,362
+100,110% +$29.6M 0.01% 639
2024
Q2
$28.4K Sell
329
-287,859
-100% -$24.2M ﹤0.01% 1823
2024
Q1
$22.7M Sell
288,188
-1,748
-0.6% -$128K 0.01% 685
2023
Q4
$19.8M Buy
289,936
+29,108
+11% +$1.89M 0.01% 720
2023
Q3
$16.6M Buy
260,828
+72,046
+38% +$4.96M 0.01% 736
2023
Q2
$12.7M Buy
188,782
+68,512
+57% +$4.29M 0.01% 794
2023
Q1
$7.34M Buy
+120,270
New +$7M ﹤0.01% 917

Other funds holding EHC

Amundi's EHC Position: Q2 2026 in Review

Amundi reduced its Encompass Health (EHC) stake by 1% in Q2 2026, selling an estimated $90.9K and leaving 87,218 shares worth $8.82M. The position accounts for ﹤0.01% of the portfolio, ranked #917.

Amundi first reported a position in EHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $30.8M in Q3 2024. 599 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Amundi held 87,218 shares of Encompass Health worth $8.82M as of Q2 2026.
  • Amundi sold 878 Encompass Health shares in Q2 2026, an estimated $90.9K.
  • Encompass Health made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #917 holding.
  • Amundi first reported a position in Encompass Health in Q1 2023 and has held it in 14 quarters since.
  • Amundi's Encompass Health position peaked at $30.8M in Q3 2024.
  • 599 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.